Product Library
Browse pharmaceutical products with CDE, DMF, and CEP registrations
Total Products
6,380
CDE Registered
2,513
DMF Registered
3,676
CEP Registered
806
Products starting with "S"
534 total, page 25 of 27| Product | CAS | CDE | DMF | CEP | Pattern | Action |
|---|---|---|---|---|---|---|
| Sodium Fusidate, Non-micronised And Micronised 夫西地酸钠 | 751-94-0 | 0 | 0 | 1 | CEP | View → |
| Simvastatin, Antioxidant Butylhydroxyanisole 辛伐他汀无润滑剂颗粒 | 79902-63-9 | 0 | 0 | 1 | CEP | View → |
| Spironolactone, Process B 螺内酯 | 52-01-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Alendronate Trihydrate 阿仑膦酸 钠 三水合物 | 121268-17-5 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 1.55 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Simvastatin, Bha Process 辛伐他汀无润滑剂颗粒 | 79902-63-9 | 0 | 0 | 1 | CEP | View → |
| Sitagliptin Phosphate Monohydrate, Process II | 654671-77-9 | 0 | 0 | 1 | CEP | View → |
| Sitagliptin Phosphate Monohydrate, Process III | 654671-77-9 | 0 | 0 | 1 | CEP | View → |
| Simvastatin, Bha, Process II 辛伐他汀无润滑剂颗粒 | 79902-63-9 | 0 | 0 | 1 | CEP | View → |
| Sorafenib Tosilate, Micronised, Polymorphic Form I | 475207-59-1 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 2.3 M3/kg, By Fermentation, For Parenteral Administration Other Than Intra-articular Administration And Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Ha-ep 3.0 (intrinsic Viscosity: 2.7-3.6 M3/kg); From Fermentation; For Parenteral Administration Including Intra-articular Administration And Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Spectinomycin Dihydrochloride Pentahydrate, Jinxi | 22189-32-8 | 0 | 0 | 1 | CEP | View → |
| Spectinomycin Sulfate Tetrahydrate For Veterinary Use, Jinxi | 64058-48-6 | 0 | 0 | 1 | CEP | View → |
| Simvastatin, With Butylated Hydroxyanisole 0.010% 辛伐他汀无润滑剂颗粒 | 79902-63-9 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 1.8 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 2.5 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Ha-e2.0 (intrinsic Viscosity 1.2-2.8 M3/kg), From Fermentation, For Parenteral Administration Other Than Intra-articular Administration And Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 2.4 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Ha-ep 1.8 (intrinsic Viscosity: 1.6-2.2 M3/kg); From Fermentation; For Parenteral Administration Including Intra-articular Administration And Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |